These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 15327527)
1. Suppressor of cytokine signalling-1 gene silencing in acute myeloid leukaemia and human haematopoietic cell lines. Watanabe D; Ezoe S; Fujimoto M; Kimura A; Saito Y; Nagai H; Tachibana I; Matsumura I; Tanaka T; Kanegane H; Miyawaki T; Emi M; Kanakura Y; Kawase I; Naka T; Kishimoto T Br J Haematol; 2004 Sep; 126(5):726-35. PubMed ID: 15327527 [TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome. Brakensiek K; Länger F; Schlegelberger B; Kreipe H; Lehmann U Br J Haematol; 2005 Jul; 130(2):209-17. PubMed ID: 16029449 [TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of the negative regulators RASSFIA, SHP-1 and SOCS-1 in myelodysplastic syndromes and acute myeloid leukaemia. Johan MF; Bowen DT; Frew ME; Goodeve AC; Reilly JT Br J Haematol; 2005 Apr; 129(1):60-5. PubMed ID: 15801956 [TBL] [Abstract][Full Text] [Related]
4. Implication of SOCS-1 gene methylation in acute myeloid leukaemia. Watanabe D; Naka T; Kishimoto T Br J Haematol; 2004 Dec; 127(5):608-9. PubMed ID: 15566367 [No Abstract] [Full Text] [Related]
5. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line. To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212 [TBL] [Abstract][Full Text] [Related]
6. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma. Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874 [TBL] [Abstract][Full Text] [Related]
7. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271 [TBL] [Abstract][Full Text] [Related]
8. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012 [TBL] [Abstract][Full Text] [Related]
9. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503 [TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Fukushima N; Sato N; Sahin F; Su GH; Hruban RH; Goggins M Br J Cancer; 2003 Jul; 89(2):338-43. PubMed ID: 12865927 [TBL] [Abstract][Full Text] [Related]
11. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling. van de Geijn GJ; Gits J; Touw IP J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455 [TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma. Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345 [TBL] [Abstract][Full Text] [Related]
13. Activity of the suppressor of cytokine signaling-3 promoter in human non-small-cell lung cancer. He B; You L; Xu Z; Mazieres J; Lee AY; Jablons DM Clin Lung Cancer; 2004 May; 5(6):366-70. PubMed ID: 15217536 [TBL] [Abstract][Full Text] [Related]
14. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843 [TBL] [Abstract][Full Text] [Related]
15. Aberrant methylation of SOCS-1 was observed in younger colorectal cancer patients. Fujitake S; Hibi K; Okochi O; Kodera Y; Ito K; Akiyama S; Nakao A J Gastroenterol; 2004; 39(2):120-4. PubMed ID: 15074307 [TBL] [Abstract][Full Text] [Related]
16. Expression of SOCS-1, suppressor of cytokine signalling-1, in human melanoma. Li Z; Metze D; Nashan D; Müller-Tidow C; Serve HL; Poremba C; Luger TA; Böhm M J Invest Dermatol; 2004 Oct; 123(4):737-45. PubMed ID: 15373779 [TBL] [Abstract][Full Text] [Related]
17. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma. Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195 [TBL] [Abstract][Full Text] [Related]
18. Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Weniger MA; Melzner I; Menz CK; Wegener S; Bucur AJ; Dorsch K; Mattfeldt T; Barth TF; Möller P Oncogene; 2006 Apr; 25(18):2679-84. PubMed ID: 16532038 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression. Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990 [TBL] [Abstract][Full Text] [Related]